AOAC Approves New Microbial Testing Validations
In a press release sent out this month, bioMérieux announced that it had received the first approvals for cannabis and hemp for performance testing methods (PTM) from the AOAC Research Institute. AOAC approved method validation for the detection of Salmonella and STEC (Shiga Toxin Producing E. coli) in cannabis flowers using bioMérieux GENE-UP® SLM2 (PTM 121802) and EHEC (PTM 121806) tests.
According to the press release, these validations are the first of their kind in the cannabis and hemp industries. The AOAC-validated test methods are approved for 1-gram and 10-gram samples.
According to Dr. Stan Bailey, Senior Director of Scientific Affairs at bioMérieux, these approvals demonstrate the company’s commitment to innovative and validated science in the cannabis and hemp industries. “We are particularly proud that GENE-UP SLM2 and EHEC are the first two AOAC approvals in the USA for cannabis and hemp,” says Dr. Bailey. “This is becoming increasingly important as more than half of the US population now lives in states that have approved cannabis for recreational use and most states approve cannabis for medical use.”
The AOAC PTM designations are recognized by the U.S. Department of Agriculture, the Food and Drug Administration, and global regulatory agencies. The validation guide builds on the AOAC’s Cannabis Analytical Science Program (CASP).
bioMérieux is a French in vitro diagnostics company serving the global test market. They offer diagnostic solutions such as systems, reagents, software and services.